In the era of innovative medicine, the Healthcare industry is facing harsh competitive business environment. Bridging west and east markets become a critical element in product success. With the theme of convergence, 2020 IQVIA JPM China Day will navigate current global pharma market environment, discuss business strategy, tactics and best practices linking west and east markets, achieving business growth and success.

MC: Kings Wang, Sr Dir, Strategic Planning & BD; Head of CS & Medical Solutions, IQVIA

9:30-9:45

Opening Remarks – Convergence Between China & US

Brian Mi, President, IQVIA GC

9:45-10:30

Market Dynamics in US & Global Market Outlook to 2024

Murray Aitken, SVP, Healthcare Insights, IQVIA

10:30-10:45

Tea break

10:45-11:30

Innovative Product Research and Development in China

Jun Bao, CEO, IMPACT Therapeutics

11:30-12:00

Sino-US Emerging Biotech’s Contribution to Global R&D Innovation

Robert Gallagher, S Principal, BIDS, IQVIA APAC

12:00-13:30 Lunch

13:30-14:00

Market Access Philosophy of Accelerated Approval Program in China

Ho Kit Chan, VP, Clinical Project Management, IQVIA GC

14:00-14:30

Go Outbound: Explore The Global Market of R&D & Commercial Strategy

Adrian McKemey, VP, Consulting, IQVIA

14:30-14:45

Tea break

14:45-15:15

Unlock China Market with Innovative Strategy & Approach

Howard Chen, Principal, Mangement Consulting, IQVIA GC

15:15-15:45

R&D innovation and commercialization: providing high quality and affordable antibody drugs for patients worldwide

Michelle Xia, Chairwoman, President and CEO, Akeso Biopharma

15:45-16:15

Panel discussion: Cross-border M&A Activities Winning Experience

Moderator: Howard Chen

Evening Reception: China Night

Venue: SLIIC Rooftop Gardens, 755 Sansome St.